LQDA
Liquidia Corporation
There isn't enough reported data to score LQDA yet.
LQDA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Strong | |
| Strong |
LQDA's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
LQDA PE Valuation
LQDA has no meaningful PE right now: it lost money over the past year.
LQDA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for LQDA, but weaker profitability. However, they disagree widely on these estimates.
LQDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.15 | — |
| Q3 2026 | -$1.20 | +$0.23 |
| Q2 2026 | $1.40 | +$3.09 |
| Q1 2026 | $0.17 | +$1.74 |
| Q4 2025 | -$0.80 | +$0.86 |
| Q3 2025 | -$1.43 | +$0.21 |
| Q2 2025 | -$1.69 | -$0.11 |
| Q1 2025 | -$1.57 | $0.00 |
| Q4 2024 | -$1.66 | -$0.45 |
LQDA is still losing money, but far less than before: $1.20 per share over the past year, against $2.60 at its worst in late 2019.
LQDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $225.3M | +315% |
| Q2 2026 | $171.7M | +1843% |
| Q1 2026 | $132.9M | +4158% |
| Q4 2025 | $92M | +3055% |
| Q3 2025 | $54.3M | +1122% |
| Q2 2025 | $8.8M | +142% |
| Q1 2025 | $3.1M | +5% |
| Q4 2024 | $2.9M | -36% |
LQDA's revenue has grown year over year for seven quarters in a row: $225M last quarter, up 315% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -117% | -120 points |
| Q2 2026 | 50% | +474 points |
| Q1 2026 | 46% | +1182 points |
| Q4 2025 | 22% | +1259 points |
| Q3 2025 | 3.3% | +660 points |
| Q2 2025 | -424% | +319 points |
| Q1 2025 | -1135% | -166 points |
| Q4 2024 | -1238% | -654 points |
LQDA's operating margin was −117% last quarter, down 120 points from the same quarter a year ago.
LQDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $129.8M | +$140.5M |
| Q2 2026 | $69M | +$109.5M |
| Q1 2026 | $50.2M | +$81.2M |
| Q4 2025 | $42.2M | +$64.3M |
| Q3 2025 | -$10.7M | +$16.1M |
| Q2 2025 | -$40.5M | -$16.6M |
| Q1 2025 | -$31M | -$5.5M |
| Q4 2024 | -$22.1M | -$5.9M |
LQDA's free cash flow has turned positive after six years mostly in the red: $291M over the past year.
LQDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.7x | Net Cash |
| Q1 2026 | -4.8x | Net Cash |
LQDA has more cash than debt.
LQDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.2 | Neutral |
| Stochastic | 37.7 | Neutral |
LQDA's weekly RSI is 52 (neutral) and its Stochastic is 38 (neutral).
LQDA PE vs Healthcare Sector
| Metric | LQDA | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 26x | 23% above |
| PE % | 16 | 29 | 13 pts below |
LQDA has no meaningful PE right now: it lost money over the past year.
LQDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $43.6 | 33% above |
| 20 week MA | $63.0 | 7.7% below |
| 50 week MA | $51.4 | 13% above |
| 100 week MA | $34.9 | 67% above |
| 200 week MA | $22.3 | 160% above |
LQDA's trend is mixed: it's above four of its five weekly moving averages, and 160% above its 200-week average.
LQDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.94 | $2.82 | -43% |
| 2021 | $2.82 | $4.67 | +66% |
| 2022 | $4.67 | $6.17 | +32% |
| 2023 | $6.17 | $12.0 | +95% |
| 2024 | $12.0 | $11.6 | -3.8% |
| 2025 | $11.6 | $34.4 | +197% |
| 2026 YTD | $34.4 | $58.1 | +69% |
LQDA's yearly returns have swung widely, from +197% in 2025 to −43% in 2020. It's up 69% so far in 2026.